The Patient-Centered Outcomes Research Institute’s issues its draft national priorities and research agenda for comment Jan. 23. Rather than identify specific research items, the list contains five broad areas designed to elicit the greatest amount of input from stakeholders on what projects should be funded for investigation.
JACKSONVILLE, FLA. – Those expecting to see a list of specific research items on the Patient-Centered Outcomes Research Institute’s draft of its initial national priorities and research agenda were probably disappointed when it was revealed that the agenda includes only broad, overarching topics.
But the reason for not narrowing the list to specifics was to allow for the greatest amount of input as...
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
The UK drug regulator acknowledges that technology will “move on” and, as such, has designed its decentralized manufacturing regulation to be as “enduring” as possible. Experts from the MHRA explain what products are covered by the new framework and how it has been future-proofed.
The European Medicines Agency expects the International Council for Harmonization’s new guideline will help address the critical lack of data on the use of medicinal products in pregnant and breastfeeding populations.
A differentiated profit-sharing model to accelerate the use of AI in drug development using clinical and patient data is being proposed in South Korea, but the idea faces multiple practical challenges
